IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
This study has been terminated.
Sponsor:
CTI BioPharma
Information provided by (Responsible Party):
CTI BioPharma
ClinicalTrials.gov Identifier:
NCT01773187
First received: January 18, 2013
Last updated: December 15, 2016
Last verified: December 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | June 2016 |
| Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |